These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 31118599

  • 21. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.
    Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Löfdahl CG.
    Respir Res; 2005 Aug 25; 6(1):98. PubMed ID: 16120227
    [Abstract] [Full Text] [Related]

  • 22. The effect of statins on survival in patients with stage IV lung cancer.
    Lin JJ, Ezer N, Sigel K, Mhango G, Wisnivesky JP.
    Lung Cancer; 2016 Sep 25; 99():137-42. PubMed ID: 27565929
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50-64 years - the SCAPIS pilot study.
    Torén K, Murgia N, Olin AC, Hedner J, Brandberg J, Rosengren A, Bergström G.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 25; 12():2269-2275. PubMed ID: 28831247
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study").
    Trigueros JA, Riesco JA, Alcázar-Navarrete B, Campuzano A, Pérez J.
    Int J Chron Obstruct Pulmon Dis; 2019 Sep 25; 14():2469-2478. PubMed ID: 31806956
    [Abstract] [Full Text] [Related]

  • 28. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW, Mortell KE, Talenfeld AD, Brunner MC.
    J Vasc Interv Radiol; 2014 Jan 25; 25(1):1-9.e1. PubMed ID: 24365502
    [Abstract] [Full Text] [Related]

  • 29. Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis.
    Owonikoko TK, Ragin C, Chen Z, Kim S, Behera M, Brandes JC, Saba NF, Pentz R, Ramalingam SS, Khuri FR.
    Oncologist; 2013 Jan 25; 18(5):600-10. PubMed ID: 23635558
    [Abstract] [Full Text] [Related]

  • 30. The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case-control study.
    Wang W, Xie M, Dou S, Cui L, Zheng C, Xiao W.
    Int J Chron Obstruct Pulmon Dis; 2018 Jan 25; 13():1167-1175. PubMed ID: 29695900
    [Abstract] [Full Text] [Related]

  • 31. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N, Hashimoto N, Morise M, Sakamoto K, Miyazaki S, Ando A, Nakahara Y, Hasegawa Y.
    Int J Chron Obstruct Pulmon Dis; 2017 Jan 25; 12():3541-3547. PubMed ID: 29270008
    [Abstract] [Full Text] [Related]

  • 32. Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.
    Langer C, Ravelo A, Hazard SJ, Guerin A, Ionescu-Ittu R, Latremouille-Viau D, Wu EQ, Ramalingam S.
    Lung Cancer; 2014 Dec 25; 86(3):350-7. PubMed ID: 25439437
    [Abstract] [Full Text] [Related]

  • 33. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.
    Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC, Gadgeel S, Soubani AO.
    J Thorac Oncol; 2009 Mar 25; 4(3):291-9. PubMed ID: 19190518
    [Abstract] [Full Text] [Related]

  • 34. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP, Marín JM, Casanova C, Pinto-Plata V, Divo M, Cote C, Celli BR, Zulueta JJ.
    Chest; 2016 Apr 25; 149(4):936-42. PubMed ID: 26513409
    [Abstract] [Full Text] [Related]

  • 35. Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P.
    Am J Respir Crit Care Med; 2020 Mar 15; 201(6):671-680. PubMed ID: 31770495
    [Abstract] [Full Text] [Related]

  • 36. Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.
    Izquierdo JL, Resano P, El Hachem A, Graziani D, Almonacid C, Sánchez IM.
    Int J Chron Obstruct Pulmon Dis; 2014 Mar 15; 9():1053-8. PubMed ID: 25336937
    [Abstract] [Full Text] [Related]

  • 37. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP.
    Arch Phys Med Rehabil; 2008 Apr 15; 89(4):595-601. PubMed ID: 18373987
    [Abstract] [Full Text] [Related]

  • 38. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY, Jian ZH, Ndi Nfor O, Jhang KM, Ku WY, Ko PC, Jan SR, Ho CC, Lung CC, Pan HH, Liang YC, Liaw YP.
    PLoS One; 2015 Apr 15; 10(7):e0133367. PubMed ID: 26196516
    [Abstract] [Full Text] [Related]

  • 39. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S, Dirican A, Tuna T.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr 15; 11():2009-15. PubMed ID: 27616884
    [Abstract] [Full Text] [Related]

  • 40. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M, Casamor R, Miravitlles M.
    Int J Chron Obstruct Pulmon Dis; 2017 Apr 15; 12():2373-2383. PubMed ID: 28848338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.